Guest: Hector O. Chapa, MD

Guest: Laura Decker, BS, RDMS, MHA

Of the 61 million women in the U.S. being of childbearing age, it is estimated that 43 million are at risk for unintended pregnancy. In 2002, the US FDA approved the first hysteroscopic sterilization device for female permanent contraception, a microinsert placed into the tubal lumen. Confirmation of placement and tubal occlusion is performed three months following insertion and has, in the past, required an invasive process. In July 2015, the FDA approved transvaginal ultrasound (TVU) as an in-office procedure and alternate confirmation test for permanent contraception microinserts as opposed to hospital-based, and which permits a faster return to routine activity for the patient. Join us as Dr. Hector Chapa and Laura Decker, a Certified Diagnostic Sonographer, discuss the emergent role that TVU plays in the confirmation of appropriate placement of permanent contraceptive microinserts, as well as an in-depth visual explanation of the confirmation process.